# Sodium Thiosulfate to Preserve Cardiac Function in STEMI

> **NCT02899364** · PHASE2 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 380 (estimated)

## Conditions studied

- Myocardial Infarction
- Heart Failure

## Interventions

- **DRUG:** Sodium thiosulfate
- **DRUG:** Sodium chloride 0.9%
- **PROCEDURE:** primary percutaneous coronary intervention
- **OTHER:** cardiac magnetic resonance imaging

## Key facts

- **NCT ID:** NCT02899364
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-20
- **Primary completion:** 2021-06-25
- **Final completion:** 2023-03
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2021-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02899364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02899364, "Sodium Thiosulfate to Preserve Cardiac Function in STEMI". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02899364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*